Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/12/09 | Quarterly report pursuant to Section 13 or 15(d) |
|
33 | ||
| 08/13/09 | Quarterly report pursuant to Section 13 or 15(d) |
|
45 | ||
| 05/14/09 | Quarterly report pursuant to Section 13 or 15(d) |
|
29 | ||
| 11/13/08 | Quarterly report pursuant to Section 13 or 15(d) |
|
27 | ||
| 08/14/08 | Quarterly report pursuant to Section 13 or 15(d) |
|
47 | ||
| 05/15/08 | Quarterly report pursuant to Section 13 or 15(d) |
|
26 | ||
| 11/14/07 | Optional form for quarterly and transition reports of small business issuers |
|
24 | ||
| 07/20/07 | Optional form for quarterly and transition reports of small business issuers |
|
23 | ||
| 05/14/07 | Optional form for quarterly and transition reports of small business issuers |
|
20 | ||
| 11/14/06 | Optional form for quarterly and transition reports of small business issuers |
|
25 |